Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/1/21 19:39 | 9/30/21 | CRVS | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | T | S.m | -25,060 | 5.01 | 0 | -5,000 | -98 | 81 | I | |||||||||||||||
9/22/21 17:27 | 9/20/21 | CRVS | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | DT | S | -6,758 | 6.09 | 0 | -1,110 | -14 | 6,944 | I | |||||||||||||||
9/22/21 17:24 | 9/20/21 | CRVS | Health | Drug | Pharmaceutical Preparations | Thompson Peter A. | CA | DT | S | -6,758 | 6.09 | 0 | -1,110 | -14 | 6,944 | I | |||||||||||||||
7/9/20 16:35 | 7/7/20 | CRVS | Health | Drug | Pharmaceutical Preparations | Novo Holdings A/s | G7 | T | S.m | -8,169 | 5.31 | 0 | -1,538 | -53 | 1,389 | D | |||||||||||||||
7/25/19 19:21 | 7/23/19 | CRVS | Health | Drug | Pharmaceutical Preparations | Novo Holdings A/s | G7 | T | S.m | -6,078 | 4.07 | 0 | -1,493 | -34 | 2,928 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |